Home LiteratureArticle Details
PMID: 4091993 Published · ppublish English Journal Article

Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine.

British journal of clinical pharmacology ·Vol. 20 ·No. 6 ·1985-12-00 ·Pages 611-8

Shaw PN, Houston JB, Rowland M, Hopkins K, Thiercelin JF, Morselli PL

Abstract

Antipyrine total clearance and the formation clearance of its major metabolites were studied in normal, healthy male volunteers before and after multiple dosing for approximately three weeks with phenytoin (six subjects) and carbamazepine (six subjects). Total antipyrine clearance increased on average by 91% after phenytoin dosing and by 61% after carbamazepine and individual increases correlated well with mean plasma concentrations of the anti-epileptic drug. The increase in total clearance resulted largely from increased formation clearances of the 4-hydroxy and 3-hydroxymethylantipyrine metabolites with minimal effect on the norantipyrine pathway, following treatment with both enzyme-inducing drugs. It is concluded that both phenytoin and carbamazepine have similar effects on antipyrine metabolism and that these effects are mediated by induction of specific forms of cytochrome P450.

MeSH Terms
Adult Antipyrine/metabolism Biotransformation Carbamazepine/administration & dosage,pharmacology Drug Interactions Half-Life Humans Kinetics Male Phenytoin/administration & dosage,pharmacology Saliva/metabolism
Chemicals
Carbamazepine Phenytoin Antipyrine
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Shaw P N
Houston J B
Rowland M
Hopkins K
Thiercelin J F
Morselli P L
References (18)
18 references, click to expand
  1. Metabolism of drugs. LIX. A new metabolite of antipyrine.
    Biochem Pharmacol. 1968 Aug;17(8):1511-6 PMID: 5672814
  2. The fate of antipyrine in man.
    J Pharmacol Exp Ther. 1950 Jan;98(1):97-104 PMID: 15403625
  3. Urinary D-glucaric acid excretion and acetanilide pharmacokinetics before and during diphenylhydantoin administration.
    Eur J Clin Pharmacol. 1974 Aug 23;7(5):387-91 PMID: 4417891
  4. Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man.
    Eur J Clin Pharmacol. 1976 Feb 6;9(4):327-32 PMID: 971716
  5. The antipyrine test in clinical pharmacology: conceptions and misconceptions.
    Clin Pharmacol Ther. 1979 Sep;26(3):275-86 PMID: 111889
  6. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
    Xenobiotica. 1979 Nov;9(11):695-702 PMID: 119355
  7. Differential effects of enzyme induction on antipyrine metabolite formation.
    Br J Clin Pharmacol. 1982 Mar;13(3):379-86 PMID: 7059438
  8. Quantitation and urinary pattern of 4,4'-dihydroxy-antipyrine, 4-hydroxy-antipyrine and 3-hydroxymethyl-antipyrine, as main metabolites of antipyrine in man and rat.
    J Pharm Pharmacol. 1982 Mar;34(3):168-75 PMID: 6121894
  9. Differential induction of antipyrine metabolism by rifampicin.
    Eur J Clin Pharmacol. 1981;21(2):155-60 PMID: 7341283
  10. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
    Eur J Clin Pharmacol. 1982;21(5):433-41 PMID: 7075648
  11. Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants.
    Eur J Clin Pharmacol. 1982;22(5):441-5 PMID: 7117357
  12. Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine.
    Br J Clin Pharmacol. 1983 Mar;15(3):317-21 PMID: 6849767
  13. Antipyrine metabolite kinetics in phenobarbital and beta-naphthoflavone-induced rats.
    Drug Metab Dispos. 1983 Mar-Apr;11(2):131-6 PMID: 6133717
  14. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo.
    Xenobiotica. 1983 Apr;13(4):223-31 PMID: 6624137
  15. Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism.
    Eur J Clin Pharmacol. 1983;25(2):215-22 PMID: 6628504
  16. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
    Xenobiotica. 1983 Aug;13(8):497-502 PMID: 6649682
  17. Effect of single and multiple doses of sulphinpyrazone on antipyrine metabolism and urinary excretion of 6-beta-hydroxycortisol.
    Eur J Clin Pharmacol. 1983;25(6):797-801 PMID: 6141054
  18. Effect of diphenylhydantoin on hepatic drug hydroxylation.
    Eur J Clin Pharmacol. 1974 Jul 26;7(4):281-5 PMID: 4851632
Article Info
Journal
British journal of clinical pharmacology
Abbr.
Br J Clin Pharmacol
ISSN
0306-5251
Published
1985-12-00
Pages
611-8
Language
English
Region
England
NLM ID
7503323
PMCID
PMC1400829
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com